Breadcrumb
  1. Home
  2. Manage the Accelerating Cancer Screening (AxCS) Award

Manage the Accelerating Cancer Screening (AxCS) Award

Find out how to manage your AxCS awards (activity code: H8I).

Jump to:

When to report progress

We require you to submit four reports:

  1. Three progress reports
  2. Final report

FY24 award recipient schedule

Report Reporting Period Available in HRSA Electronic Handbooks (EHBs) Due Date
1 September 1, 2024 to February 28, 2025 March 1, 2025 March 15, 2025
2 March 1, 2025 to August 31, 2025 September 1, 2025 September 15, 2025
3 September 1, 2025 to February 28, 2026 March 1, 2026 March 15, 2026
Final September 1, 2024 to August 31, 2026 August 31, 2026 November 29, 2026

FY23 award recipient schedule

Report Reporting Period Available in EHBs Due Date
1 February 1, 2023 to 
July 31, 2023
August 1, 2023 August 15, 2023
2 August 1, 2023 to 
January 31, 2024
February 1, 2024 February 15, 2024
3 February 1, 2024 to 
July 31, 2024
August 1, 2024 August 15, 2024
Final February 1, 2023 to 
January 31, 2025
January 31, 2025 May 1, 2025

FY22 award recipient schedule

Report Reporting Period Available in EHBs Due Date
1 September 1, 2022 to 
February 28, 2023
March 1, 2023 March 15, 2023
2 March 1, 2023 to 
August 31, 2023
September 1, 2023 September 15, 2023
3 September 1, 2023 to 
February 28, 2024
March 1, 2024 March 15, 2024
Final September 1, 2022 to 
August 31, 2024
August 31, 2024 November 29, 2024

Find resources for your award

Add a grant to your EHBs portfolio (add your H8I grant folder).

Frequently Asked Questions (FAQ)

AxCS FAQ

FY23 award aids

FY22 award aids

Notice of Funding Opportunity (NOFO)

FY22 HRSA-22-154 NOFO

Application aids

May 10, 2022, Applicant TA webinar | May 10, 2022, Applicant TA webinar slides (PDF - 986 KB) 

Attachments and forms

Find technical assistance

Our resources

Partner resources

Get key award details

Our funding supports President Biden's call to action on cancer screening and early detection as part of the Administration's Cancer Moonshot initiative. 

We aim to reduce the cancer death rate by at least 50% over the next 25 years and support families living with and surviving cancer.

You will use AxCS funds to achieve two objectives:

  1. Increase the number and percentage of patients screened for at least one of the following cancer types: cervical, breast, or colorectal.
  2. Increase the number of patients assisted with accessing appropriate follow-up care (for example, diagnostic services, therapies, clinical trials) within 30 days of receiving an abnormal cancer screening test result.

We support you increasing equitable access to cancer screening and referral for care and treatment by enhancing education, case management, outreach, and other enabling services. 

You should partner or coordinate with National Cancer Institute (NCI)-designated Cancer Centers. They will deploy outreach specialists and patient navigators for populations that you serve.

Contact us

If you have a question about: You can reach us at:
Your award Email the Project Officer listed on your Notice of Award
Budget Email the Grants Management Specialist listed on your Notice of Award
EHBs 

Complete the BPHC Contact Form

Under Technical Support, select EHBs Tasks/EHBs Technical Issues 

Call 877-464-4772 (select option 1) 8 a.m. – 8 p.m. ET, Monday – Friday (except federal holidays)

Fecha de la última revisión: